Tech Company Financing Transactions
MBrace Therapeutics Funding Round
On 11/14/2023, MBrace Therapeutics raised $85 million in Series B funding from TPG Capital, Alta Partners and Avidity Partners.
Transaction Overview
Company Name
Announced On
11/14/2023
Transaction Type
Venture Equity
Amount
$85,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to support clinical development programs, including a first-in-human clinical trial of lead investigational ADC, MBRC-101.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4660 La Jolla Village Dr. 950
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
MBrace Therapeutics is a privately held biopharmaceutical business dedicated to improving cancer patients' quality of life by developing antibody-drug conjugates (ADCs) against novel oncology targets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Isan Chen
Founder
Wadih Arap
Founder
Renata Pasqualini
Browse more venture capital transactions:
Prev: 11/14/2023: Keychain venture capital transaction
Next: 11/15/2023: Evenergi Labs venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs